1. Screening Libraries
  2. Kinase Inhibitor Library

Kinase Inhibitor Library

Cat. No.: HY-L009
Library Contents: XLSX PDF

A unique collection of 839 phosphorylation kinase inhibitors/regulators for high throughput screening (HTS) and high content screening (HCS).

Kinase Inhibitor Library
Size (Pre-dissolved DMSO or Solid) Price Stock
30 μL/well (10 mM solution) Get quote In-stock
50 μL/well (10 mM solution) Get quote In-stock
100 μL/well (10 mM solution) Get quote In-stock
250 μL/well (10 mM solution) Get quote In-stock

Please contact us at

[email protected]

Top Publications Citing Use of Products
  • Description

  • Product Details

  • Composition

  • Contents

  • Documentation

Description
& Advantages

•   A unique collection of 839 phosphorylation kinase inhibitors/regulators for high throughput screening (HTS) and high content screening (HCS).

•   The library contains compounds targeting protein kinases (VEGFR, EGFR, BTK, CDK, Akt, etc.), lipid kinases (PI3K, PI4K, SK, etc.) and carbohydrate kinases (Hexokinase).

•   Kinase inhibitors have played an increasingly prominent role in the treatment of cancer and other diseases.

•   Bioactivity and safety confirmed by preclinical research and clinical trials. Some inhibitors have been approved by FDA.

•   Structurally diverse, medicinally active, and cell permeable.

•   Rich documentation with structure, IC50, and customer reviews.

•   NMR and HPLC validated to ensure high purity.

•   All compounds are in stock and continuously updated.

Product Details
Formulation:
A collection of 839 kinase inhibitors/regulators supplied as pre-dissolved DMSO solutions or Solid
Container:
96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
Storage:
-80°C
Shipping:
Blue ice
Composition

Kinase Inhibitor Library

Source: MedChem Express

Contents of Kinase Inhibitor Library

Plate layout: HY-L009-1

1 2 3 4 5 6 7 8 9 10 11 12
a Empty MRT68921 (hydrochloride) AZD0156 LY3177833 NT157 Flavopiridol Flavopiridol (Hydrochloride) SNS-032 TA-01 AZD-5438 GSK'481 Empty
b Empty R547 EAI045 AM-2394 IQ-1 GSK583 NVP-BAW2881 PF-04979064 MLi-2 WYE-132 AEE788 Empty
c Empty GSK2256098 Tyrphostin AG 528 NPS-1034 RAF709 NVS-PAK1-1 MSDC 0160 Necrosulfonamide NH125 APS-2-79 Y-33075 Empty
d Empty LM22A-4 Y-27632 IPI549 TPCA-1 PF-06651600 TAK-659 (hydrochloride) SAR-20347 CEP-40783 HA-100 RIPA-56 Empty
e Empty Src Inhibitor 1 LY294002 AS-605240 IC-87114 TG100-115 TP-3654 TGX-221 PI-103 PI-103 (Hydrochloride) ZINC00881524 Empty
f Empty Barasertib-HQPA AZD1152 GDC-0326 ZM-447439 PD-166866 RG14620 RG13022 ISCK03 SUN11602 BAY-1895344 (hydrochloride) Empty
g Empty M3814 Nilotinib Nilotinib (monohydrochloride monohydrate) Tozasertib MSC2530818 LTURM34 IMD-0354 PHA-680632 Danusertib MLN8054 Empty
h Empty Dasatinib Dasatinib (hydrochloride) CHIR-99021 CHIR-99021 (monohydrochloride) GSK'872 Linsitinib NVP-TAE 684 LYN-1604 hydrochloride AZD-1480 BTK IN-1 Empty

Plate layout: HY-L009-2

1 2 3 4 5 6 7 8 9 10 11 12
a Empty SMI-16a Wortmannin BMS-754807 Sorafenib Sorafenib (Tosylate) Tandutinib OSI-930 Cediranib Amuvatinib Dovitinib (lactate) Empty
b Empty Pazopanib Masitinib Masitinib (mesylate) CUDC-101 Motesanib Motesanib (Diphosphate) Saracatinib BRAF inhibitor RAF265 GSK-690693 Empty
c Empty NVP-ADW742 AG1024 PD0325901 Sunitinib SB 203580 SB 203580 (hydrochloride) Vandetanib Afatinib Afatinib (dimaleate) BMS-536924 Empty
d Empty SB 202190 Omipalisib LY3200882 Repotrectinib PIK-294 ABT-702 dihydrochloride Doramapimod PD173074 Falnidamol D4476 Empty
e Empty CL-387785 GW788388 Neflamapimod JNJ-7706621 Toceranib Regorafenib Regorafenib (monohydrate) Brivanib (alaninate) Brivanib Foretinib Empty
f Empty KW-2449 KX2-391 (dihydrochloride) KX2-391 (Mesylate) Fasudil (Hydrochloride) Enzastaurin Sotrastaurin AZD 6482 AKT inhibitor VIII MK 2206 (dihydrochloride) THZ531 Empty
g Empty BI-78D3 Canertinib (dihydrochloride) PF-06409577 Pim1/AKK1-IN-1 PP121 Semaxinib PD173955 VX-702 Losmapimod PH-797804 Empty
h Empty Talmapimod SU 5402 Fedratinib TG101209 AZD-8055 Milciclib SB-431542 A 83-01 sodium salt TAK-715 PF-562271 (besylate) Empty

Plate layout: HY-L009-3

1 2 3 4 5 6 7 8 9 10 11 12
a Empty PF-562271 PF-573228 Torkinib Dinaciclib BMS-794833 SU14813 SU14813 (maleate) BI-D1870 1-(4-Methoxybenzyl)-3-(5-nitrothiazol-2-yl)urea BX795 Empty
b Empty Orantinib BMS-345541 BMS-345541 (free base) CGP 57380 GSK1904529A Telatinib ARRY-380 (analog ) GW 5074 CYC-116 PD 169316 Empty
c Empty Pluripotin GSK 3 Inhibitor IX Y-27632 (dihydrochloride) TWS119 Ro 28-1675 Ningetinib Tosylate Ningetinib 6-Bromo-2-hydroxy-3-methoxybenzaldehyde 2-Phospho-L-ascorbic acid trisodium salt EG00229 Empty
d Empty CCT 137690 AG126 LRRK2-IN-1 Lazertinib GW2580 GNF-7 FLT3-IN-1 Momelotinib Momelotinib sulfate SB-590885 Empty
e Empty Alisertib Tivozanib Lenvatinib ENMD-2076 (Tartrate) ENMD-2076 MGCD-265 analog AZD-7762 Adavosertib Ibrutinib Trametinib Empty
f Empty Trametinib (DMSO solvate) GSK429286A PHA-793887 CP-466722 GW843682X AZ 628 BX-912 KU-57788 GNF-2 CGP60474 Empty
g Empty A-484954 TDZD-8 WHI-P97 SB 239063 Pilaralisib Nintedanib esylate PHA-665752 R406 (free base) CZC-8004 LX2343 Empty
h Empty SM 16 eCF506 SLV-2436 BMS-986195 GDC-0575 O-304 AZ32 SJ000291942 ETC-206 MBQ-167 Empty

Plate layout: HY-L009-4

1 2 3 4 5 6 7 8 9 10 11 12
a Empty CGI-1746 AG-490 SNS-314 Erlotinib (Hydrochloride) Pazopanib (Hydrochloride) BMS-599626 (Hydrochloride) SB 216763 PD153035 (Hydrochloride) SU11274 KU-55933 Empty
b Empty PF-04217903 PF-04217903 (methanesulfonate) Vatalanib (dihydrochloride) SGX-523 WZ4002 PD98059 U0126 WYE-354 AMG-208 GSK1059615 Empty
c Empty Rigosertib (sodium) Ki8751 Lyn-IN-1 SP600125 Pimasertib SB 525334 Cabozantinib (S-malate) HMN-214 PIK-93 Ponatinib Empty
d Empty Chelerythrine Chloride CCT129202 CP-673451 Hesperadin BIX02188 BIX02189 Vemurafenib AZD8330 AT7867 AT7867 (dihydrochloride) Empty
e Empty KRN-633 KU-60019 PD318088 PHT-427 R406 PI3K-IN-1 DPH LDN193189 (Hydrochloride) Lck Inhibitor BMS 777607 Empty
f Empty Poloxin Volasertib TAK-901 Lorlatinib PI-3065 CID755673 DMH-1 ML347 FR 180204 AZ191 Empty
g Empty K02288 Umbralisib Serabelisib Defactinib Defactinib (hydrochloride) IM-12 WH-4-023 CFI-400945 (free base) CFI-400945 (fumarate) Kenpaullone Empty
h Empty AZD8186 KRCA-0008 HTH-01-015 UNC2025 UNC2025 (hydrochloride) ETC-1002 Gilteritinib Y15 Decernotinib PF-06447475 Empty

Plate layout: HY-L009-5

1 2 3 4 5 6 7 8 9 10 11 12
a Empty SAR405 LY-2584702 (tosylate salt) LDC1267 ISRIB (trans-isomer) ANA-12 SKF-86002 LY3023414 Bikinin Ro-3306 LY3009120 Empty
b Empty ZM39923 (hydrochloride) URMC-099 ON123300 Acalisib LDC4297 Entrectinib ITD-1 GNE-317 BLZ945 IC261 Empty
c Empty L-779450 Vps34-PIK-III Vps34-IN-1 BLU9931 MK2-IN-1 (hydrochloride) Mirk-IN-1 CCT196969 BAY1217389 LOXO-101 (sulfate) PQR309 Empty
d Empty AZD-8835 AMG319 R-268712 TP-0903 SGI-7079 S49076 PRT-060318 Quizartinib Torin 2 PF-3758309 Empty
e Empty CH5424802 CH5424802 (Hydrochloride) RepSox Cabozantinib MRT67307 GSK1838705A CC-401 (hydrochloride) DCC-2036 CAL-101 LY2784544 Empty
f Empty R788(Disodium) R788 (disodium hexahydrate) Cediranib (maleate) Sapitinib ACHP (Hydrochloride) Cobimetinib Cobimetinib (hemifumarate) E-7050 CHIR-98014 NVP-TAE 226 Empty
g Empty Crenolanib LY2157299 SD-208 YM-201636 CDK9-IN-1 GSK2578215A LY2228820 GDC-0980 MK-5108 AMG 900 Empty
h Empty OSI-420 Thiazovivin NVP-BHG712 CCT128930 A66 CHIR-124 WP1130 BS-181 Dacomitinib IRAK inhibitor 1 Empty

Plate layout: HY-L009-6

1 2 3 4 5 6 7 8 9 10 11 12
a Empty IRAK inhibitor 2 IRAK inhibitor 3 IRAK inhibitor 6 PIK-75 SGI-1776 KN-62 Mps1-IN-1 SR-3677 LY2874455 Regorafenib (Hydrochloride) Empty
b Empty NVP-BGJ398 NVP-BGJ398 (phosphate) JNK-IN-8 ASP3026 INK-128 IRAK-1-4 Inhibitor I AZD4547 NVP-BGT226 Apatinib ZM 336372 Empty
c Empty INCB28060 AICAR AICAR (phosphate) Dorsomorphin (dihydrochloride) Deguelin TAK-733 CID 2011756 PHA-767491 (hydrochloride) LY-364947 ALK-IN-1 Empty
d Empty HG-10-102-01 GNF-5837 Mubritinib Mitoxantrone Mitoxantrone (dihydrochloride) Piceatannol Nocodazole SB-505124 CUDC-907 AG-1478 Empty
e Empty CAY10505 AS-252424 BPR1J-097 Hydrochloride AZM475271 Oclacitinib (maleate) Chrysophanol (-)-Epigallocatechin Gallate PQ401 IKK 16 Go 6983 Empty
f Empty Oglufanide R1530 Valrubicin ZM 306416 SC-514 PP1 PP2 MK-8745 GSK2656157 SKI II Empty
g Empty PLX647 BX517 PF-4989216 Ro 31-8220 (mesylate) WHI-P154 PD168393 CNX-2006 GDC-0032 VE-822 Flumatinib Empty
h Empty Flumatinib (mesylate) TCS 359 Hydroxyfasudil Hydroxyfasudil (hydrochloride) PND-1186 PD0166285 1-Naphthyl PP1 1-Naphthyl PP1 (hydrochloride) 1-NM-PP1 CNX-774 Empty

Plate layout: HY-L009-7

1 2 3 4 5 6 7 8 9 10 11 12
a Empty BML-277 SRPIN340 2-Deoxy-D-glucose DDR1-IN-1 Mps1-IN-2 B-Raf inhibitor 1 VX-11e PD153035 Emodin TBB Empty
b Empty MP7 XMD8-92 PF-03814735 Palomid 529 Genistein [6]-Gingerol Dabrafenib Dabrafenib (Mesylate) CP-724714 Refametinib Empty
c Empty AZ3146 Reversine CCT241533 (hydrochloride) LY2603618 EMD-1214063 NVP-BSK805 (dihydrochloride) VE-821 AS 602801 Tideglusib GSK2334470 Empty
d Empty BAY 61-3606 (dihydrochloride) AST 487 5-Aminosalicylic Acid NG 52 MLN0905 SBE13 (Hydrochloride) TAK-960 TAK-960 (dihydrochloride) Icotinib (Hydrochloride) Icotinib Empty
e Empty SB1317 BEZ235 (Tosylate) PF-04691502 NVP-BKM120 (Hydrochloride) GDC-0068 GDC-0068 (dihydrochloride) GSK 650394 EMD638683 TAK-285 CEP-32496 Empty
f Empty MEK162 CHR-6494 c-Kit-IN-1 NVP-LCQ195 BYL-719 GSK2636771 MLN 2480 AZD2014 GDC-0349 XL413 (hydrochloride) Empty
g Empty BMS-911543 BMS-265246 AIM-100 CZC24832 SLx-2119 WP1066 Baricitinib Baricitinib (phosphate) PRT062607 (Hydrochloride) AG 555 Empty
h Empty CVT-313 CEP-33779 ALK inhibitor 2 5-Iodotubercidin AZD5363 SL327 SB 415286 NVP-BVU972 Triciribine SAR131675 Empty

Plate layout: HY-L009-8

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Imatinib CH5132799 ZM323881 (hydrochloride) MLN120B TTP 22 PF-670462 AXL1717 JANEX-1 Tyrphostin A9 TC-DAPK 6 Empty
b Empty LY2801653 CGK733 ETP-46464 kb NB 142-70 DMAT FRAX486 GSK269962A AZ20 SSR128129E AZD1208 Empty
c Empty AZD-3463 GDC-0623 TIC10 AG 18 LDK378 LDK378 (dihydrochloride) IPA-3 XMD17-109 GZD824 SAR407899 (hydrochloride) Empty
d Empty SAR407899 CRT0066101 dihydrochloride LH846 NU 7026 Afuresertib Afuresertib (hydrochloride) CO-1686 CO-1686 (hydrobromide) Poziotinib GNF-5 Empty
e Empty XL228 RKI-1447 Necrostatin-1 AZD2858 A 419259 (trihydrochloride) TAK-632 ONO-4059 ONO-4059 (hydrochloride) AZD-9291 AZD-9291 (mesylate) Empty
f Empty PF-4708671 LEE011 LEE011 (hydrochloride) LEE011 (succinate) LEE011 (succinate hydrate) K145 (hydrochloride) UNC2250 UNC2881 CZC-25146 WZ4003 Empty
g Empty VRT752271 NMS-1286937 ID-8 CEP-37440 STF-083010 HS-173 LDC000067 TCS JNK 5a AMG 925 (HCl) LDN-212854 Empty
h Empty SAR245409 ML167 GSK2141795 GS-9973 H-89 (dihydrochloride) APY0201 Cerdulatinib Irbinitinib AT13148 AZD7545 Empty

Plate layout: HY-L009-9

1 2 3 4 5 6 7 8 9 10 11 12
a Empty JI-101 LY2090314 LY2835219 LY2835219 (free base) Pacritinib Phenformin (hydrochloride) XL-147 Butein Resveratrol TCS-PIM-1-4a Empty
b Empty VS-5584 CNX-1351 ZLN024 (hydrochloride) LDN-214117 Acumapimod Pexidartinib Solcitinib Pexmetinib JH-II-127 CC-223 Empty
c Empty Sitravatinib CC-115 CC-115 (hydrochloride) Duvelisib Duvelisib (R enantiomer) Metformin (hydrochloride) APY29 Acalabrutinib Belizatinib PS-1145 Empty
d Empty LFM-A13 AVL-292 CEP-28122 (mesylate salt) GSK2606414 Quercetin TCS PIM-1 1 CX-6258 CX-6258 (hydrochloride hydrate) CCT241736 GNE-7915 Empty
e Empty GNE-7915 (tosylate) AZD2932 Purvalanol B Purvalanol A GLPG0634 BMS-3 BMS-5 GW 441756 FIIN-2 PD158780 Empty
f Empty SU9516 Ro 5126766 Centrinone Centrinone-B AMG-337 Erdafitinib SCR-1481B1 BQR-695 SC79 AZD3759 Empty
g Empty WEHI-345 ONO-4059 (analog) BI-847325 CCT245737 CHZ868 TAS-301 PLX8394 GSK180736A 3-Methyladenine NU2058 Empty
h Empty Compound 401 T56-LIMKi Peficitinib NVP-ACC789 MCB-613 Tauroursodeoxycholate (Sodium) trans-Zeatin 4μ8C LJH685 LJI308 Empty

Plate layout: HY-L009-10

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Olmutinib STO-609 Indirubin-3'-monoxime EGFR-IN-3 Avitinib (maleate) SC66 GDC-0853 PF06650833 Fruquintinib EW-7197 Empty
b Empty EW-7197 Hydrochloride CH5183284 YU238259 PF-06459988 3-Bromopyruvic acid GDC-0941 (dimethanesulfonate) Tyrphostin AG 879 Roscovitine Pelitinib Neratinib Empty
c Empty Tofacitinib Tofacitinib (citrate) GDC-0941 CI-1040 AT9283 A-769662 JNJ-38877605 Tivantinib BI 2536 Selumetinib Empty
d Empty KU-0063794 Linifanib Palbociclib (hydrochloride) ZSTK474 CX-4945 CX-4945 (sodium salt) Ruxolitinib Ruxolitinib (phosphate) GDC-0879 Bafetinib Empty
e Empty GSK461364 Crizotinib Crizotinib (hydrochloride) Gefitinib Gefitinib (hydrochloride) Erlotinib Lapatinib Lapatinib (ditosylate) BIBF 1120 Dovitinib Empty
f Empty Perifosine Temsirolimus AT7519 AT7519 (Hydrochloride) Imatinib (Mesylate) PLX-4720 Tolimidone GSK-1070916 Aurora A inhibitor I NVP-BKM120 Empty
g Empty Poloxime MNS A 77-01 THZ1 THZ1 (Hydrochloride) Palbociclib (isethionate) Lonidamine Methylthiouracil Amlexanox Bucladesine (sodium salt) Empty
h Empty Bucladesine (calcium salt) LY2409881 SU6656 Altiratinib CZC-54252 AZ-5104 MHY1485 Danthron Trapidil Flufenamic acid Empty

Plate layout: HY-L009-11

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Chloropyramine hydrochloride Metadoxine Honokiol Oridonin Verbascoside Ginsenoside Rb1 Ginsenoside Re Ferulic acid Salidroside Dihydromyricetin Empty
b Empty Neohesperidin dihydrochalcone Formononetin Bakuchiol Pachymic acid Wogonin Cucurbitacin E Quercitrin Astragaloside IV Corynoxeine Carnosol Empty
c Empty Dicoumarol Dehydrocorydaline (chloride) Harmine Scutellarin Scutellarein Isovitexin Isorhamnetin Ginkgolide C Ingenol Magnolin Empty
d Empty 1,3-Dicaffeoylquinic acid Loureirin B Loureirin A Hispidulin Palmitelaidic Acid 7-Hydroxy-4H-chromen-4-one 7-Methoxyisoflavone Protein kinase inhibitors 1 hydrochloride 2,5-Dihydroxybenzoic acid Empty Empty
e Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
f Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
g Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
h Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
Documentation

Inquiry Online

Your information is safe with us. * Required Fields.

Product name

 

Salutation

Applicant name *

 

Email address *

Phone number *

 

Organization name *

Country or Region *

 

Requested quantity *

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Kinase Inhibitor Library
Cat. No.:
HY-L009
Quantity:

Request SDF File

Please enter your email address. We will send your requested SDF file to you as soon as possible.